Skip to main content

Table 3 Basic blood parameters in the FO group (n = 18) and MPL group (n = 15) at the beginning of the study (E1) and after 6 weeks (E2)

From: Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial

Blood parameter (mean)

E1

E2

P-value

change

CRP (mg/dl)*

FO

33.7 ± 65.8

15.6 ± 21.3

0.98

-54%

MPL

30.6 ± 68.9

10.4 ± 11.5

0.95

−66%

Albumin (g/dl)

FO

3.73 ± 0.64

3.76 ± 0.63

0.76

+0,8%

MPL

3.69 ± 0.68

3.89 ± 0.55

0.31

+5,4%

Leukocytes (n/nl)*

FO

7.78 ± 4.3

7.46 ± 4.93

0.59

-4%

MPL

7.88 ± 4.90

6.68 ± 2.09

0.40

−15%

Thrombocytes (n/nl)

FO

296.3 ± 151.0

244.1 ± 121.1

0.01**

-18%

MPL

363.5 ± 254.6

270.9 ± 113.1

0.12

−25%

Triglycerides (mg/dl)

FO

112.1 ± 45.2

99.3 ± 45.1

0.33

-11%

MPL

130.1 ± 78.0

116.6 ± 41.9

0.64

−10%

Cholesterol (mg/dl)

FO

159.6 ± 47.0

161.8 ± 47.0

0.78

+1%

MPL

170.5 ± 42.7

179.2 ± 35.7

0.31

+5%

LDL (mg/dl)

FO

90.8 ± 34.4

86.9 ± 39.4

0.54

-4%

MPL

99.7 ± 33.9

109.8 ± 33.6

0.11

+10%

HDL (mg/dl)*

FO

51.3 ± 24.8

62.6 ± 28.7

0.00**

+22%

MPL

48.1 ± 16.4

50.4 ± 8.64

0.48

+5%

VLDL (mg/dl)*

FO

20.4 ± 13.5

18.0 ± 9.4

0.29

-12%

MPL

23.9 ± 16.6

21.6 ± 10.9

0.74

-10%

GOT (U/l)*

FO

39.3 ± 35.6

42.6 ± 32.3

0.03**

+8%

MPL

26.3 ± 7.41

29.4 ± 7.99

0.14

+12%

GPT (U/l)*

FO

41.4 ± 44.9

48.4 ± 48.4

0.18

+17%

MPL

25.7 ± 8.99

36.0 ± 27.5

0.12

+40%

CHE (U/l)*

FO

5558.8 ± 1880.3

5788.9 ± 1780.3

0.30

+4%

MPL

5388.9 ± 1630.8

5817.5 ± 1282.2

0.18

+8%

Ratio LDL/HDL

FO

2.05 ± 0.90

1.63 ± 0.91

0.01**

-20%

MPL

2.6 ± 2.4

2.3 ± 1.04

0.60

-12%

  1. E1, E2 = examination1, 2, * non-normally distributed, ** statistically significant